首页> 外文期刊>NFS Journal >Barriers to adoption of biogenic carbonates in the food, pharmaceutical & supplement sectors
【24h】

Barriers to adoption of biogenic carbonates in the food, pharmaceutical & supplement sectors

机译:食品,药品和补品行业采用生物碳酸盐的障碍

获取原文
       

摘要

There is an increasing demand for environmentally sustainable sourcing of ingredients for the food, pharmaceutical and supplements industries. In the case of calcium carbonate (E170) as by-products from the egg and shellfish processing industries these have the potential to be sustainably sourced. In addition to their green credentials, biogenic carbonates have intrinsic benefits in terms of their chemical composition, such as a low heavy metal burden. However, their biogenic origin can potentially lead to manufacturing issues such as higher levels of co-mineralising components and the organic templates of their natural production. This contribution identifies the regulatory barriers to the adoption of biogenic eggshell calcium carbonate by assessing materials from biological sources along with commercial precipitated and ground carbonates against current regulatory standards.
机译:对于食品,制药和补品行业而言,对环境可持续采购原料的需求不断增长。就鸡蛋和贝类加工工业的副产品碳酸钙(E170)而言,有可能可持续地获得。除了绿色环保外,生物碳酸盐还具有化学成分方面的固有优势,例如重金属含量低。但是,它们的生物起源可能会导致制造问题,例如更高水平的共矿化成分和其自然生产的有机模板。通过根据当前法规标准评估来自生物来源的材料以及商业沉淀和研磨的碳酸盐,这项贡献确定了采用生物蛋壳型碳酸钙的法规障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号